Home > Healthcare > Medical Devices > Diagnostic Devices > Sleep Apnea Devices Market

Sleep Apnea Devices Market Size

  • Report ID: GMI489
  • Published Date: Dec 2024
  • Report Format: PDF

Sleep Apnea Devices Market Size

The global sleep apnea devices market size was valued at USD 7.2 billion in 2024 and is expected to exhibit growth at a CAGR of 7.8% from 2025 to 2034. High market growth can be attributed to the increasing incidence of sleep apnea and related comorbidities, surging awareness of sleep apnea and sleep disorders, and the rising aging population amplifying demand, among other contributing factors.

 

Sleep apnea is a prevalent condition affecting millions of individuals globally, with many cases remaining undiagnosed. According to the National Institutes of Health, nearly 1 billion people worldwide suffer from sleep apnea, including 936 million cases of obstructive sleep apnea. The rising prevalence of sleep apnea can be attributed to factors such as an aging population, increasing obesity rates, and lifestyle changes.
 

As awareness grows about the serious health risks of untreated sleep apnea—including cardiovascular diseases, diabetes, and stroke—more individuals are seeking medical intervention. This surge in awareness and diagnosis has significantly increased the demand for sleep apnea devices, driving growth in this market.
 

Additionally, the increasing awareness of sleep apnea symptoms such as loud snoring, daytime fatigue, and difficulty concentrating has encouraged more people to seek medical evaluation. Enhanced diagnostic techniques, such as home sleep tests and in-lab polysomnography, have made it easier to identify cases of sleep apnea. As more people are diagnosed with the condition, the demand for sleep apnea devices, including CPAP (continuous positive airway pressure) machines, BiPAP, and other therapeutic devices, continues to grow.
 

Sleep apnea devices are medical apparatuses designed to manage and treat sleep apnea by ensuring unobstructed breathing during sleep. These devices play a crucial role in mitigating the health risks associated with untreated sleep apnea, thereby enhancing patient outcomes and quality of life.
 

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The global sleep apnea devices industry was valued at USD 7.2 billion in 2024 and is projected to grow at a 7.8% CAGR from 2025 to 2034, driven by the increasing prevalence of sleep apnea and related comorbidities.

The therapeutics segment generated USD 4.6 billion in revenue in 2024, led by the dominance of CPAP and BiPAP machines due to their proven efficacy in treating obstructive sleep apnea (OSA).

The U.S. sleep apnea devices market recorded USD 2.5 billion in revenue in 2024 and is expected to grow at a 7.4% CAGR from 2025 to 2034, supported by the expansion of the private healthcare sector and increased access to diagnostic and therapeutic solutions.

Key players in the market include Asahi KASEI, BMC, Cadwell, Drive DeVilbiss, Fisher & Paykel, Itamar Medical, Philips, LivaNova, Natus, Nihon Kohden, ResMed, and Teleflex.

Sleep Apnea Devices Market Scope

Buy Now


Premium Report Details

  • Base Year: 2024
  • Companies covered: 13
  • Tables & Figures: 232
  • Countries covered: 19
  • Pages: 135
 Download Free Sample